x

Rechercher un projet de recherche

* (*) Champ obligatoire

77 Résultat(s)

Trier par

Financé par un membre IRDiRC =

Projets de recherche

ALLEMAGNE

Baden-Württemberg
HEIDELBERG

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

ALLEMAGNE

Baden-Württemberg
MANNHEIM

ALLEMAGNE

Baden-Württemberg
ULM

ALLEMAGNE

Baden-Württemberg
ULM

Characterising normal versus leukemic stem cells in patients with acute myeloic leukemia (German Cancer Aid)
Universitätsklinikum Ulm
Institut für Experimentelle Tumorforschung

ALLEMAGNE

Baden-Württemberg
ULM

Evaluation of Incidence and Prognostic Importance of Gene Mutations in acute myeloid leukemia (AML)
Universitätsklinikum Ulm am Oberen Eselsberg
Klinik für Innere Medizin III

ALLEMAGNE

Baden-Württemberg
ULM

Design and Evaluation of Real-Time RT-PCR Assays for the Detection of Minimal Residual Disease in AML
Universitätsklinikum Ulm am Oberen Eselsberg
Klinik für Innere Medizin III

ALLEMAGNE

Baden-Württemberg
ULM

ALLEMAGNE

Hessen
MARBURG

A synthetic lethal screen to identify novel targets for therapy in acute myeloid leukemia
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Innere Medizin - Schwerpunkt Hämatologie, Onkologie und Immunologie

ALLEMAGNE

Hessen
MARBURG

Epigenetics of the nuclear oncogene Ski in AML (SPP 1463: Epigenetic regulation of normal hematopoiesis and its dysregulation in myeloid neoplasia)
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Innere Medizin - Schwerpunkt Hämatologie, Onkologie und Immunologie

ALLEMAGNE

Hessen
MARBURG

Cooperation of Ras induced signaling and the nuclear oncogene Ski in acute myeloid leukemia (AML) and malignant melanoma (TRR 17: Ras-dependent pathways in human cancer)
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Innere Medizin - Schwerpunkt Hämatologie, Onkologie und Immunologie

ALLEMAGNE

Niedersachsen
HANNOVER

AML-BFM Registry 2012: Clinical registry for children and adolescents with acute myeloid leukemia
KPOH Geschäftsführung Hannover
Kompetenznetz Pädiatrische Onkologie und Hämatologie

ALLEMAGNE

Niedersachsen
HANNOVER

Signal transduction of c-Kit and c-Kit related tyrosine kinases: mRNA export and hematopoesis
Medizinische Hochschule Hannover
Institut für Physiologische Chemie

ALLEMAGNE

Niedersachsen
HANNOVER

The histamine H2-receptor as new target for differentiation therapy in acute myeloic leukemia
Medizinische Hochschule Hannover
Institut für Pharmakologie

ALLEMAGNE

Nordrhein-Westfalen
ESSEN

AML-BFM Registry 2012: Clinical registry for children and adolescents with acute myeloid leukemia
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie

ALLEMAGNE

Sachsen
DRESDEN

AML Registry: Clinical AML Registry
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Medizinische Klinik und Poliklinik I

AUTRICHE

STEIERMARK
GRAZ

The role of RKIP in myeloid leukemogenesis
Medizinische Universität Graz
Klinische Abteilung für Hämatologie

AUTRICHE

STEIERMARK
GRAZ

Subclonal TP53 mutations in acute myeloid leukemia
Medizinische Universität Graz
Klinische Abteilung für Hämatologie

AUTRICHE

WIEN
WIEN

Functional interactions between EVI1 and atRA in LSCs (in acute myeloid leukemia)
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie

BELGIQUE

VLAAMS BRABANT
LEUVEN

The role of RAS- and RHO-GTPases, their regulators and mediators in the pathogenesis of myeloid malignancies.
University Hospitals Leuven - Gasthuisberg
Laboratory for Genetics of Malignant Disorders

CANADA

Ontario
TORONTO

Financé par un membre IRDiRCCD123-Targeted Auger Electron Radioimmunotherapy of Acute Myelogenous Leukemia (AML)
University of Toronto
Leslie Dan Faculty of Pharmacy, University of Toronto

ESPAGNE

Andalucía
CÓRDOBA

Financé par un membre IRDiRCImplications of immunosenescence in the design of antitumor immunotherapy protocols based on NK cells in melanoma and acute myeloid leukemia models
IMIBIC - Instituto Maimónides de Investigación Biomédica de Córdoba
GC01 T and NK cell Immunosenescence Antiviral Immune Response

ESPAGNE

Cataluña
BARCELONA

Financé par un membre IRDiRCClonal heterogeneity in acute myeloid leukemia: immunophenotypic and genotypic characterization and by generation of xenografts
IIB Sant Pau - Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Grupo de investigación clínica en oncología

ESPAGNE

Comunidad Valenciana
VALENCIA

ESPAGNE

Comunidad Valenciana
VALENCIA

Financé par un membre IRDiRCTracking and validation of mutations in the non-coding regions and spliceosome genes in acute myeloblastic leukemia (AML)
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de investigación en hematología y hemoterapia

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US

Financé par un membre IRDiRCTherapeutics for rare and neglected diseases - science
Institution: Information not provided - US

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US

Financé par un membre IRDiRCA novel compound for targeted treatment of cbf leukemia
Institution: Information not provided - US

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US

Financé par un membre IRDiRCMechanistic and translational studies of cbf leukemia
Institution: Information not provided - US

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US

Financé par un membre IRDiRCMolecular pathogenesis of chromosome 16 inversion in human leukemia
Institution: Information not provided - US

SUEDE

Stockholms läns landsting
HUDDINGE

Molecular pathogenesis in myelodysplastic syndromes and acute myeloid leukemia
Karolinska Institutet - Huddinge
Department of Medicine

SUEDE

Stockholms läns landsting
STOCKHOLM

Study of chemotherapy resistance and DNA methylation in acute myeloid leukemia samples
Karolinska Universitetssjukhuset - Huddinge
Hematology Centre

ESPAGNE

Madrid
MADRID

Financé par un membre IRDiRCMassive sequencing contributes to decipher the genetic bases of families with rare tumors
Centro Nacional de Investigaciones Oncológicas (CNIO)
Grupo de Genética Humana

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Financé par un membre IRDiRCENCCA: EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS - FR
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent

FRANCE

ILE-DE-FRANCE
PARIS

Financé par un membre IRDiRCSTaHR : Stimulation de la Recombinaison Homologue pour la Thérapie Génique - FR
Muséum National d'Histoire Naturelle
Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196

FRANCE

PAYS DE LA LOIRE
NANTES

Financé par un membre IRDiRCFROGH : Etude Génétique de la Population Française - FR
Institut de Recherche en Santé - Université de Nantes
L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291

ITALIE

CAMPANIA
NAPOLI

Financé par un membre IRDiRCTelethon Undiagnosed Disease Program - Revised Proposal
TIGEM - Telethon Institute of Genetics and Medicine
Genomic Medicine - Telethon Institute of Genetics and Medicine

JAPON

JAPAN
ADDRESS : NOT PROVIDED - JP

JAPON

JAPAN
ADDRESS : NOT PROVIDED - JP

ALLEMAGNE

Baden-Württemberg
HEIDELBERG

Financé par un membre IRDiRCERA-NET TRANSCAN: TORPEDO - Targeting Of Resistance in PEDiatric Oncology (coordination)
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US

FRANCE

ILE-DE-FRANCE
ORSAY

ITALIE

LOMBARDIA
MILANO

RARECARE: surveillance of rare cancers in Europe (coordination)
Fondazione IRCCS Istituto Nazionale dei Tumori
S.S. di Epidemiologia Valutativa

ROYAUME-UNI

Greater London
LONDON

Financé par un membre IRDiRCUK Infrastructure for Large-scale Clinical Genomics Research
Barts and The London School of Medicine and Dentistry
William Harvey Research Institute

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

Financé par un membre IRDiRCNewcastle University Single Cell Functional Genomics Unit (NUSCU)
Newcastle University
Institute of Genetic Medicine

ROYAUME-UNI

Tyne & Wear
NEWCASTLE UPON TYNE

EPOC: European paediatric oncology off-patent medicines consortium (coordination)
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

Projets de recherche multicentriques